Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Mar 23, 2018. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 76045-105-20
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)
- Initial Posting
- Mar 23, 2018
Reason
Other